Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,170 | -17,200 | -10,060 | -7,830 | -5,311 |
| Depreciation Amortization | 132 | 44 | 50 | 16 | N/A |
| Other Working Capital | 990 | -350 | 66 | 2,379 | 1,070 |
| Other Operating Activity | 7,407 | 4,627 | 2,798 | 424 | 319 |
| Operating Cash Flow | $-16,641 | $-12,879 | $-7,146 | $-5,011 | $-3,922 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -373 | -241 | -247 | -475 | -429 |
| Other Investing Activity | 3,719 | 3,719 | 3,719 | 0 | 0 |
| Investing Cash Flow | $3,346 | $3,478 | $3,472 | $-475 | $-429 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 500 | N/A |
| Common Stock Issued | 530 | N/A | 12,413 | N/A | N/A |
| Other Financing Activity | 178,156 | 38,858 | 26,816 | 0 | 500 |
| Financing Cash Flow | $178,686 | $38,858 | $39,229 | $500 | $500 |
| Beginning Cash Position | 564 | 564 | 564 | 5,550 | 5,550 |
| End Cash Position | 165,955 | 30,021 | 36,119 | 564 | 1,699 |
| Net Cash Flow | $165,391 | $29,457 | $35,555 | $-4,986 | $-3,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,641 | -12,879 | -7,146 | -5,011 | -3,922 |
| Capital Expenditure | -373 | -241 | -247 | -475 | -429 |
| Free Cash Flow | -17,014 | -13,120 | -7,393 | -5,486 | -4,351 |